Evidence map›Paper›PMID 24565038›Full record

ReviewStem cell research & therapy2013

Novel in vitro respiratory models to study lung development, physiology, pathology and toxicology.

Joan E Nichols, Jean A Niles, Stephanie P Vega, Joaquin Cortiella

Open access · goldAbstract readReview
In one paragraph

Review in Stem cell research & therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. HumanAsia Pacific allergy · 2019
    Review
  9. The asbestos-carbon nanotube analogy: An update.Toxicology and applied pharmacology · 2018
    Review
  10. Article
  11. An Inventory of Methods for the Assessment of Additive Increased Addictiveness of Tobacco Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Review
  12. 3D tissue-engineered model of Ewing's sarcoma.Advanced drug delivery reviews · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joan E Nichols
Jean A Niles
Stephanie P Vega
Joaquin Cortiella
The University of Texas Medical Branch at Galveston · US

Funding

3D human lung model to study lung disease and formation of fibrosisU18TR000560 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI NICHOLS, JOAN ELIZABETH · 2012 to 2013
$611k
NCATS NIH HHS 1-U18-TR-000560
6 · The paper itself

Abstract

Detailed studies of lung pathology in patients during the course of development of acute lung injury or respiratory distress are limited, and in the past information related to lung-specific responses has been derived from the study of lungs from patients who died at autopsy or from animal models. Development of good in vitro human tissue models would help to bridge the gap in our current knowledge of lung responses and provide a better understanding of lung development, physiology and pathology. In vitro models of simple one-cell or two-cell culture systems as well as complex multicellular lung analogs that reproduce defined components of specific human lung responses have already been realized. A benefit of current in vitro lung models is that hypotheses generated from review of data from human or animal disease studies can be tested directly in engineered human tissue models. Results of studies done using simple in vitro lung systems or more complex three-dimensional models have already been used to examine cell-based responses, physiologic functions, pathologic changes and even drug toxicity or drug responses. In the future we will create models with specific genetic profiles to test the importance of single gene products or pathways of significance. Recent development of microfluidics-based models that support high-throughput screening will allow early-stage toxicity testing in human systems and faster development of new and innovative medical products. Model design in the future will also allow for evaluation of multiple organ systems at once, providing a more holistic or whole-body approach to understanding human physiology and responses.

Indexed as

AnimalsCell DifferentiationEmbryonic Stem CellsEpithelial CellsHumansInduced Pluripotent Stem CellsLungLung DiseasesMicrofluidic Analytical TechniquesModels, BiologicalPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein A

Identifiers

PMID24565038
PMCPMC4028843
OpenAlexW2096458399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.